Successful treatment of atelectasis with Dornase alpha in a patient with congenital muscular dystrophy
A 28-year-old neuromuscular patient chronically treated with nocturnal noninvasive ventilation developed pulmonary lobar atelectasis and daytime hypoxemia. Twenty four-hour 5Â L/min oxygen was begun, while mechanical cough assist aids were applied for seven days. In the following three days, treatme...
Main Authors: | G. Crescimanno, O. Marrone |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Revista Portuguesa de Pneumologia |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0873215913000226 |
Similar Items
-
DORNASE ALPHA: THREE CLINICAL EFFECTS
by: O.I. Simonova
Published: (2008-03-01) -
DORNASE ALPHA: THREE CLINICAL EFFECTS
by: O.I. Simonova
Published: (2008-03-01) -
Dornase alpha use in patients with cystic fibrosis
by: Paulo José C. Marostica
Published: (2013-12-01) -
High frequency chest wall oscillation plus Mechanical In-Exsufflation in Duchenne muscular dystrophy with respiratory complications related to pandemic Influenza A/H1N1
by: G. Crescimanno, et al.
Published: (2010-11-01) -
Congenital Muscular Dystrophy
by: Khadilkar SV, et al.
Published: (2005-01-01)